BIOL Stock | News | Quote | Stock Forum | Tuesday, December 24,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 24, 2013 at 11:38 PM

$BIOL Biolase, Inc. BIOL Company Overview

Stock Message Board http://investorshangout.com/search?q=BIOL&...mp;yt1=Go!

Last Updated: Tuesday, December 24, 2013 11:37:50 PM

Biolase, Inc. BIOL Current Price and Quotes
Last Price 2.04
Previous Close 2.15 Open 2.15
Daily Range 2.16 - 2.01 52wk Range 5.96 - 1.15
Volume 135,242 Dividend N/A
Average Vol (3m) 328,661 Yield N/A
Biolase, Inc. BIOL
Company Information

4 Cromwell
Irvine, CA 92618

Phone: (949) 361-1200

Biolase, Inc. BIOL
Not Available

Biolase, Inc. BIOL
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000811240
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=Biolase Technology, Inc. until 5-2012
Formerly=Laser Medical Technology, Inc. to 6-94
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Biolase, Inc. BIOL
BIOL Security Details

Share Structure

Market Value1 $55,973,915 a/o Dec 24, 2013
Shares Outstanding 34,301,105 a/o Dec 12, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 197 a/o Mar 16, 2009
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Dec 12, 2013 Dec 16, 2013 Dec 30, 2013
Dividend (0.00) Aug 28, 2013 Aug 30, 2013 Sep 13, 2013
Dividend (0.00) Jun 12, 2013 Jun 14, 2013 Jun 28, 2013
Security Notes

Capital Change=3-2-92 shs decreased by 1 for 2 reverse split
Capital Change=Stk. Div.=1% Ex-date=03/11/2011. Rec date=03/15/2011. Pay date=03/31/2011.
Capital Change=Stk. Div.=1% Ex-date=06/08/2011. Rec date=06/10/2011. Pay date=06/30/2011.
Capital Change=Stk. Div.=1% Ex-date=08/25/2011. Rec date=08/29/2011. Pay date=09/15/2011.
Capital Change=Stk. Div.=0.5% Ex-date=03/13/2012. Rec date=03/15/2012. Pay date=03/30/2012.
Capital Change=shs increased by 1.005 for 1 split Ex-date=06/06/2012. Rec date=06/08/2012. Pay date=06/25/2012.
Capital Change=shs increased by 1.005 for 1 split Ex-date=09/12/2012. Rec date=09/14/2012. Pay date=09/28/2012.
Capital Change=shs increased by 1.005 for 1 split Ex-date=12/12/2012. Rec date=12/14/2012. Pay date=12/28/2012.
Capital Change=shs increased by 1.005 for 1 split Ex-date=03/13/2013. Rec date=03/15/2013. Pay date=03/29/2013.
Capital Change=shs increased by 1.005 for 1 split Ex-date=06/12/2013. Rec date=06/14/2013. Pay date=06/28/2013.
Capital Change=shs increased by 1.005 for 1 split Ex-date=08/28/2013. Rec date=08/30/2013. Pay date=09/13/2013.
Capital Change=shs increased by 1.005 for 1 split. Ex-date=12/12/2013. Rec date=12/16/2013. Pay date=12/30/2013.
Short Selling Data

Short Interest 452,004 (-5.26%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)

Computershare Trust Company Inc.

Biolase, Inc. BIOL Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 57,356 48,858 26,225 43,347
Cost of Revenue 30,878 27,540 17,400 23,285
Gross Profit 26,478 21,318 8,825 20,062
Operating Expenses

Research and Development 4,684 4,311 3,790 4,146
Sales, General and Admin. 24,325 21,011 16,495 18,876
Non-Recurring Items - - 35 -
Other - - - -
Operating Income (2,531) (4,004) (11,495) (2,960)
Income From Continuing Operations

Add'l Income/Expense Items (175) (88) (107) 181
Earnings Before Interest and Tax (2,706) (4,092) (11,602) (2,779)
Interest Expense 239 305 361 58
Earnings Before Tax (2,945) (4,397) (11,963) (2,837)
Income Tax 111 89 58 119
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,056) (4,486) (12,021) (2,956)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,056) (4,486) (12,021) (2,956)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,056) (4,486) (12,021) (2,956)

Biolase, Inc. BIOL Recent News

Dec 11, 2013 BIOLASE Engages Piper Jaffray & Co. as Financial Advisor
Dec 11, 2013 BIOLASE Adds Two New Independent Directors to Its Board
Dec 5, 2013 BIOLASE Declares Stock Dividend for 2013 Fourth Quarter
Dec 2, 2013 BIOLASE Introduces GALAXY BioMill CAD/CAM System at Greater New York Dental Meeting
Dec 2, 2013 BIOLASE to Present at LD Micro Conference
Nov 22, 2013 BIOLASE Kicks off Medical Laser Marketing by Exhibiting at MEDICA 2013
Nov 11, 2013 BIOLASE to Introduce Galaxy BioMill(TM) CAD/CAM System
Nov 11, 2013 BIOLASE to Explore Possible M&A Transactions
Nov 11, 2013 BIOLASE Reports 2013 Third Quarter, Nine-Month Results
Nov 4, 2013 BIOLASE to Host Third Quarter 2013 Results Conference Call and Webcast on November 11th at 4:30 p.m. EST

1
2
next >

BIOL Biolase, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BIOL&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIOL/quote
Stock Chart http://www.otcmarkets.com/stock/BIOL/chart
Company Info http://www.otcmarkets.com/stock/BIOL/company-info
Recent News http://www.otcmarkets.com/stock/BIOL/news
Financials http://www.otcmarkets.com/stock/BIOL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIOL/filings
Short Sales http://www.otcmarkets.com/stock/BIOL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIOL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIOL/research
Summary http://finance.yahoo.com/q?s=BIOL
Historical Prices http://finance.yahoo.com/q/hp?s=BIOL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIOL
Basic Chart http://finance.yahoo.com/q/bc?s=BIOL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIOL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIOL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIOL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIOL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIOL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIOL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIOL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIOL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIOL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIOL
Balance Sheet http://finance.yahoo.com/q/bs?s=BIOL
Cash Flow http://finance.yahoo.com/q/cf?s=BIOL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIOL
Market Watch http://www.marketwatch.com/investing/stock/BIOL
Bloomberg http://www.bloomberg.com/quote/BIOL:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIOL
Bussinessweek http://investing.businessweek.com/research/st...icker=BIOL
Barchart http://www.barchart.com/quotes/stocks/BIOL
OTC Short Report http://otcshortreport.com/index.php?index=BIOL
Investopedia http://www.investopedia.com/markets/stocks/BIOL/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoGenesis Showcases STING Agonist Progress at SITC

STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....

PeptideWorld Paves the Way for Innovative Peptide Education

The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...

FIS Slashes Forecast: Guidance Under Scrutiny Now

Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....

Basildon Build-to-Rent Marks Progress for Starlight

Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...

Bluevua Triumphs with Three BASA Awards Wins

Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...

Satisfi Labs Secures Two AI Patents, Boosts Reach

Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...

Omnicom Media: A Titan in Media Management Unveiled

Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...

Young Storytellers Honored: Bridging Cultures Through Journalism

Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...

New Story Appoints Drudge, Celebrates Workplace Recognition

A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...

Crocs™ Gains C2C Circularity Gold for Classic Clogs

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...